Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ribosomal protein S23 pseudogene is a **non-coding genomic sequence** derived from the processing and insertion of mRNA from the ribosomal protein S23 gene (RPS23) back into the genome. While the functional RPS23 gene encodes a component of the small (40S) ribosomal subunit involved in protein synthesis in eukaryotic cells[1][3][5][6], the pseudogene itself does **not produce a functional protein**. Pseudogenes such as this one are common for ribosomal protein genes and are dispersed throughout the genome[5][6]. There is no evidence that this pseudogene has a direct role in health or disease, and it is not a therapeutic target nor a candidate biomarker in current scientific literature[3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S23 pseudogene.